+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat



Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat



Hepatology 52(2): 667-677



Ursodeoxycholic acid (UDCA) induces bicarbonate-rich hypercholeresis by incompletely defined mechanisms that involve the stimulation of adenosine triphosphate (ATP) release from cholangiocytes. As nitric oxide (NO) at a low concentration can stimulate a variety of secretory processes, we investigated whether this mediator could be implicated in the choleretic response to UDCA. Our in vivo experiments with the in situ perfused rat liver model in anesthetized rats, showed that UDCA infusion increased the biliary secretion of NO derivatives, hepatic inducible NO synthase expression, and NO synthase activity in liver tissue. UDCA also stimulated NO release by isolated rat hepatocytes. In contrast to UDCA, cholic acid was a poor inducer of NO secretion, and tauroursodeoxycholic acid showed no effect on NO secretion. Upon UDCA administration, NO was found in bile as low-molecular-weight nitrosothiols, of which S-nitrosoglutathione (GSNO) was the predominant species. UDCA-stimulated biliary NO secretion was abolished by the inhibition of inducible NO synthase with N(omega)-nitro-L-arginine methyl ester in isolated perfused livers and also in rats whose livers were depleted of glutathione with buthionine sulfoximine. Moreover, the biliary secretion of NO species was significantly diminished in UDCA-infused transport mutant [ATP-binding cassette C2 (ABCC2)/multidrug resistance-associated protein 2 (Mrp2)-deficient] rats, and this finding was consistent with the involvement of the glutathione carrier ABCC2/Mrp2 in the canalicular transport of GSNO. It was particularly noteworthy that in cultured normal rat cholangiocytes, GSNO activated protein kinase B, protected against apoptosis, and enhanced UDCA-induced ATP release to the medium; this effect was blocked by phosphoinositide 3-kinase inhibition. Finally, retrograde GSNO infusion into the common bile duct increased bile flow and biliary bicarbonate secretion. UDCA induces biliary secretion of GSNO, which contributes to stimulating ductal secretion.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051793660

Download citation: RISBibTeXText

PMID: 20683964

DOI: 10.1002/hep.23709


Related references

Hypercholeresis induced by ursodeoxycholic acid in primary biliary cirrhosis. Journal of Hepatology 18(SUPPL 1): S120, 1993

Ursodeoxycholic acid induced hypercholeresis in a patient with primary biliary cirrhosis. Hepatology 18(4 PART 2): 297A, 1993

Inhibition of ursodeoxycholic acid induced hypercholeresis by sodium replacement or amiloride is associated with replacement of unconjugated ursodeoxycholic acid by ursodeoxycholic acid glucuronides in bile. Hepatology 5(5): 1010, 1985

Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis. Scandinavian Journal of Gastroenterology 26(5): 513-522, 1991

Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sciences 79(10): 1014-1019, 2006

Ursodeoxycholic acid induced biliary bicarbonate secretion is inhibited by heavy water. Journal of Hepatology 11(SUPPL 2): S30, 1990

Effect of simvastatin ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia. Hepatology 15(6): 1072-1078, 1992

Hypercholeresis induced by unconjugated dihydroxy bile acid infusion requires biliary secretion of unconjugated bile acids. Hepatology 5(5): 1023, 1985

Effect of ursodeoxycholic acid on biliary lipid secretion and bile acid metabolism in primary biliary cirrhosis. Hepatology 8(5): 1317, 1988

Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis. Digestive Diseases and Sciences 34(12 Suppl): 52s-58s, 1989

Biliary secretion of unconjugated bile acids in patients with primary biliary cirrhosis pbc before and following ursodeoxycholic acid administration. Gastroenterology 98(5 PART 2): A578, 1990

Biliary secretion of ursodeoxycholic acid udca taurine and glycine conjugates sulfates and glucuronides in patients with external biliary drainage. Hepatology 14(4 PART 2): 260A, 1991

High biliary bicarbonate concentration and hypercholeresis induced by a bisnorbile acid derivative in the anesthetized rat. Journal of Physiology (Cambridge) 424: 68P, 1990

Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects. Italian Journal of Gastroenterology 27(8): 441-445, 1995

Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis. Digestive Diseases and Sciences 34(12 Suppl): 5s-15s, 1989